Aggression - 371 Studies Found Terminated : A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies : Advanced Solid Tumors Aggressive B-cell Lymphomas : 2014-07-18 : Biological: MEDI6469 Monotherapy Completed : Impact Study of 2 Therapeutic Strategy for Aggressive Remitting Multiple Sclerosis : Multiple Sclerosis : 2010-02-08 : Other: mitoxantrone - immunomodulator Completed : Trauma and Truth Interventions (NET) Versus Conflict Resolution and Social Skills Trainings for Vulnerable Youths in Northern Uganda : PTSD Depression Aggression : 2009-05-04 : Behavioral: NET Truth Education Completed : A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma : Non-Hodgkin's Lymphoma : 2005-09-12 : Drug: Clofarabine Clofarabine 30 mg/m2/day will be administered as a 2-hour intravenous infusion (IVI) o Completed : Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability : Irritable Mood Aggression Tra : 2008-02-21 : Drug: Amantadine Amantadine 100 mg every morning and 12 noon Completed : Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen : B-Cell Lymphomas : 2011-10-12 Completed : Gemcitabine/Clofarabine/Busulfan and Allogeneic Transplantation for Aggressive Lymphomas : Lymphoma : 2012-10-03 : Drug: Gemcitabine Recruiting : Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma : Lymphoma : 2015-03-12 : Drug: Pegfilgrastim 6 mg subcu Completed : Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL : Non Hodgkin's Lymphoma NHL Aggressiv : 2010-03-16 : Drug: Veltuzumab and 90Y-Epratuzumab Tetraxetan Completed : Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas : Lymphoma, High-grade : 2007-11-05 : Drug: (R-)CHOP protocol Patien <<< Previous | Next >>>
